Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User (Biopharma Companies, CROs, CMOs) - Global Forecast 2026
The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. Single-use bioprocessing is a rapidly evolving technology used to develop disposable bioprocessing equipment and accessories to manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind using single-use bioprocessing technology in the bioprocess is to decrease the cost associated with complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.
“The single-use media bags and containerssegment accounted for the highest growth rate in the single use bioprocessingmarket, byproduct, during the forecast period”
In 2020, the single-use media bags and containers segment accounted for the largest shareof the single use bioprocessing market, mainly because they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.
“Filtrationsegment accounted for the largest share of the application segment”
In 2020, the filtration application accounted for the largest share.A single-use capsule filter, for instance, serves as an effective substitute for stainless steel housings that require the installation of filter elements. Considering that a fully integrated, single-use system, including the filter, bag, tubing, and other components, is manufactured and sterilized as one eliminates the contamination risks associated with aseptic connections during coupling. Single-use filtration systems also ensure that operators do not come in contact with cleaning solutions, cytotoxic fluids, or buffers with extreme pH.The single-use nature of this type of filtration system eliminates the need for system maintenance, cleaning and cleaning validation and avoids any possibility of contamination from product to product or batch to batch.
“Asia Pacific: The fastest-growing regionin thesingle use bioprocessingmarket”
Thesingle use bioprocessing market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). Significant investments by key market players, increasing government support, and developing R&D infrastructure are the major factors fueling the growth of the singleuse bioprocessing market in the Asia Pacific region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of thesingle use bioprocessing market. It aims at estimating the size and future growth potential of the market across different segments such as theproduct, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall singleuse bioprocessing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.
“The single-use media bags and containerssegment accounted for the highest growth rate in the single use bioprocessingmarket, byproduct, during the forecast period”
In 2020, the single-use media bags and containers segment accounted for the largest shareof the single use bioprocessing market, mainly because they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.
“Filtrationsegment accounted for the largest share of the application segment”
In 2020, the filtration application accounted for the largest share.A single-use capsule filter, for instance, serves as an effective substitute for stainless steel housings that require the installation of filter elements. Considering that a fully integrated, single-use system, including the filter, bag, tubing, and other components, is manufactured and sterilized as one eliminates the contamination risks associated with aseptic connections during coupling. Single-use filtration systems also ensure that operators do not come in contact with cleaning solutions, cytotoxic fluids, or buffers with extreme pH.The single-use nature of this type of filtration system eliminates the need for system maintenance, cleaning and cleaning validation and avoids any possibility of contamination from product to product or batch to batch.
“Asia Pacific: The fastest-growing regionin thesingle use bioprocessingmarket”
Thesingle use bioprocessing market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). Significant investments by key market players, increasing government support, and developing R&D infrastructure are the major factors fueling the growth of the singleuse bioprocessing market in the Asia Pacific region.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80%and Demand Side 20%
- By Designation: C-level - 25%, D-level - 20%, and Others - 55%
- By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%
- Sartorius Stedim Biotech S. A. (France)
- Danaher Corporation (US)
- Thermo Fisher Scientific (US)
- Merck KGaA (Germany)
- Getinge AB (Sweden)
- Eppendorf AG (Germany)
- Corning (US)
- Entegris (US)
- Avantor (US)
- CESCO Bioengineering Co. Ltd. (Taiwan)
- Cellexus (UK)
- PBS Biotech, Inc. (US)
- Distek, Inc. (US)
- ABEC, Inc. (US)
- Able Corporation &Biott Corporation (Japan)
- G&G Technologies (US)
- Solida Biotech GmbH (Germany)
- Satake Chemical Equipment Mfg., Ltd. (Japan)
- Stobbe Pharma GmbH (Switzerland)
- Celltainer Biotech (Netherlands)
- Meissner Filtration roducts, Inc. (US)
- bbi-biotech GmbH (Germany)
- Pierre Guerin (France)
- Kuhner AG (Switzerland)
- OmniBRx Biotechnologies (India).
This report provides a detailed picture of thesingle use bioprocessing market. It aims at estimating the size and future growth potential of the market across different segments such as theproduct, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall singleuse bioprocessing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY SOURCES: SINGLE-USE BIOPROCESSING MARKET
2.2 MARKET SIZE ESTIMATION
FIGURE 2 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
FIGURE 3 SINGLE-USE BIOPROCESSING MARKET: FINAL MARKET (USD BILLION)
FIGURE 4 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOPROCESSING MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
2.3.1 KEY INDUSTRY INSIGHTS
2.3.2 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 6 MEDIA BAGS AND CONTAINERS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
FIGURE 7 FILTRATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET DURING THE FORECAST PERIOD
FIGURE 8 CROS AND CMOS TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET DURING THE FORECAST PERIOD
FIGURE 9 GEOGRAPHICAL SNAPSHOT: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET IN 2020
4 PREMIUM INSIGHTS
4.1 SINGLE-USE BIOPROCESSING MARKET OVERVIEW, 2021 VS. 2026
FIGURE 10 RISING DEMAND FOR BIOPHARMACEUTICALS IS A KEY DRIVER FOR
MARKET GROWTH
4.2 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT &
COUNTRY (2021)
FIGURE 11 MEDIA BAGS AND CONTAINERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
4.3 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
FIGURE 12 THE FILTRATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET IN 2020
4.4 SINGLE-USE BIOPROCESSING MARKET, BY END USER
FIGURE 13 BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE END USERS SEGMENT IN 2020
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 14 SINGLE-USE BIOPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 The growing demand for biopharmaceuticals
5.1.1.2 Reduced investments for single-use bioprocessing technologies
FIGURE 15 IMPACT ON VARIOUS PARAMETERS: SINGLE-USE SYSTEMS VS. STAINLESS STEEL SYSTEMS
5.1.1.3 Faster implementation and lower risk of product cross-contamination
5.1.2 RESTRAINTS
5.1.2.1 Issues related to leachables and extractables
TABLE 1 KEY EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging markets
5.1.3.2 Patent Expiry
FIGURE 16 US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
5.1.4 CHALLENGES
5.1.4.1 Waste disposal
TABLE 2 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
5.1.4.2 Issues associated with scalability
5.2 PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS (2020)
5.2.1 THREAT FROM NEW ENTRANTS
5.2.2 THREAT FROM SUBSTITUTES
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF COMPETITIVE RIVALRY
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF THE ECOSYSTEM OF SINGLE-USE BIOPROCESSING: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.4 PRICING ANALYSIS
TABLE 3 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS BY REGION (2019)
5.5 TECHNOLOGICAL ANALYSIS
5.6 IMPACT OF COVID-19 OUTBREAK ON THE SINGLE-USE BIOPROCESSING MARKET
6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 5 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
6.2 SINGLE-USE MEDIA BAGS AND CONTAINERS
6.2.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESSING OPERATIONS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
TABLE 6 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2017–2020 (USD MILLION)
TABLE 7 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2021–2026 (USD MILLION)
TABLE 8 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 9 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 10 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 11 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 12 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 13 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
6.3 SINGLE-USE ASSEMBLIES
6.3.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE ASSEMBLIES
TABLE 14 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 17 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 18 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 19 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 20 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 21 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.4 SINGLE-USE BIOREACTORS
6.4.1 SINGLE-USE BIOREACTOR SYSTEMS OFFER GREAT FLEXIBILITY OF OPERATIONS
TABLE 22 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 25 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 26 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 27 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 29 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.5 DISPOSABLE MIXERS
6.5.1 DISPOSABLE MIXERS OFFER REDUCED RISK OF CROSS CONTAMINATION WHICH DRIVES THE GROWTH OF THIS SEGMENT
TABLE 30 DISPOSABLE MIXERS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 31 DISPOSABLE MIXERS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 32 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 33 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 34 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 35 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 36 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 37 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.6 OTHER PRODUCTS
TABLE 38 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 41 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 42 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 43 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 45 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 46 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 47 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
7.2 FILTRATION
TABLE 48 FILTRATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 49 FILTRATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 51 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 52 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 53 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 54 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 55 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.3 STORAGE
7.3.1 SINGLE-USE STORAGE SYSTEMS OFFER COST SAVINGS ON STERILIZATION PROCESS
TABLE 56 STORAGE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 57 STORAGE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 59 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 60 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 61 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 62 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 63 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.4 CELL CULTURE
7.4.1 SINGLE-USE CELL CULTURE PRODUCTS OFFER REDUCED RISK OF CONTAMINATION
TABLE 64 CELL CULTURE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 65 CELL CULTURE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 67 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 68 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 69 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 70 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 71 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.5 MIXING
7.5.1 DISPOSABLE MIXING SYSTEMS ARE COST-EFFICIENT, PREVENTING CLEANING AND STERILIZATION CHARGES
TABLE 72 MIXING APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 73 MIXING APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 75 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 76 EUROPE: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 77 EUROPE: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 79 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.6 PURIFICATION
7.6.1 SINGLE-USE PURIFICATION PRODUCTS ARE INCREASINGLY IN DEMAND OWING TO FLEXIBILITY OF USE
TABLE 80 PURIFICATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 81 PURIFICATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 82 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 83 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 84 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 85 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 87 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
8 SINGLE-USE BIOPROCESSING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 88 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 89 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
8.2 BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES
8.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOPROCESSING EQUIPMENT IN THIS END-USER SEGMENT
TABLE 90 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION)
TABLE 91 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 93 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 94 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 95 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 96 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 97 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF CROS AND CMOS
TABLE 98 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2017–2020 (USD MILLION)
TABLE 99 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2021–2026 (USD MILLION)
TABLE 100 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 101 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 102 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 103 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 104 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 105 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS &
CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES
TO DRIVE THE MARKET GROWTH
TABLE 106 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)
TABLE 107 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)
TABLE 108 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 109 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 110 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 111 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 113 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
9 SINGLE-USE BIOPROCESSING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 114 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 115 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
TABLE 116 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 117 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 118 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 119 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 120 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
9.2.1 US
9.2.1.1 The growing focus on biopharmaceutical production in the US drives the market growth
TABLE 124 US: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.2.2 CANADA
9.2.2.1 The increasing incidences of lifestyle diseases such as cancer drive the market growth for biologics in Canada
TABLE 130 CANADA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.3 EUROPE
TABLE 136 EUROPE: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing adoption of single-use bioprocessing equipment by biopharma and CDMO companies to drive the market growth
TABLE 144 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 145 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 146 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 147 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 148 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 149 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies in the UK
TABLE 150 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 151 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 152 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 153 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 154 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 155 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing investments in life sciences R&D infrastructure development to drive the market growth in France
TABLE 156 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 157 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 158 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 159 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 160 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 161 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.4 REST OF EUROPE (ROE)
TABLE 162 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 163 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 164 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 165 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 166 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 167 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
TABLE 168 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
FIGURE 21 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
9.4.1 CHINA
9.4.1.1 Government support and significant private investments to drive the market growth in China
TABLE 176 CHINA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing biomanufacturing investments to favor the market growth
TABLE 182 JAPAN: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Low manufacturing and labor costs make India a lucrative country for single-use bioprocessing equipment manufacturers
TABLE 188 INDIA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 194 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 195 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 196 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 197 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 198 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 199 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.5 LATIN AMERICA (LATAM)
9.5.1 BRAZIL ACCOUNTS FOR THE LARGEST SHARE OF THE LATAM REGION FOR SINGLE-USE BIOPROCESSING IN 2020
TABLE 200 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 201 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 202 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 203 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 204 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 205 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA (MEA)
9.6.1 THE GROWTH OF THE BIOTECHNOLOGY INDUSTRY IN THIS REGION DRIVES THE WIDE ADOPTION OF SINGLE-USE BIOPROCESSING PRODUCTS
TABLE 206 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 207 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 208 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 209 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 210 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 211 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 MARKET EVALUATION FRAMEWORK
10.2 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION QUADRANT
10.2.1 STARS
10.2.2 EMERGING LEADERS
10.2.3 PERVASIVE
10.2.4 PARTICIPANTS
FIGURE 22 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION MATRIX, 2020
10.3 MARKET RANK ANALYSIS
FIGURE 23 SINGLE-USE BIOPROCESSING MARKET: MARKET RANKING OF KEY PLAYERS (2020)
10.4 COMPETITIVE SCENARIO
10.4.1 KEY PRODUCT LAUNCHES
10.4.2 KEY ACQUISITIONS
10.4.3 KEY PARTNERSHIPS AND AGREEMENTS
10.4.4 KEY EXPANSIONS
11 COMPANY PROFILES
(Business overview, Products offered, Recent Developments,SWOT Analysis, MNM view)*
11.1 SARTORIUS STEDIM BIOTECH
TABLE 212 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
FIGURE 24 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
11.2 DANAHER CORPORATION
TABLE 213 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.3 THERMO FISHER SCIENTIFIC
TABLE 214 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.4 MERCK KGAA
TABLE 215 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.5 GETINGE AB
TABLE 216 GETINGE AB: BUSINESS OVERVIEW
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2020)
11.6 EPPENDORF AG
TABLE 217 EPPENDORF AG: BUSINESS OVERVIEW
FIGURE 29 EPPENDORF: COMPANY SNAPSHOT (2020)
11.7 CORNING
TABLE 218 CORNING: BUSINESS OVERVIEW
FIGURE 30 CORNING COMPANY SNAPSHOT (2020)
11.8 ENTEGRIS
TABLE 219 ENTEGRIS: BUSINESS OVERVIEW
FIGURE 31 ENTEGRIS COMPANY SNAPSHOT (2020)
11.9 AVANTOR
TABLE 220 AVANTOR: BUSINESS OVERVIEW
FIGURE 32 AVANTOR: COMPANY SNAPSHOT (2020)
11.10 CESCO BIOENGINEERING CO., LTD.
TABLE 221 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
11.11 CELLEXUS
TABLE 222 CELLEXUS: BUSINESS OVERVIEW
11.12 PBS BIOTECH, INC.
TABLE 223 PBS BIOTECH, INC.: BUSINESS OVERVIEW
11.13 DISTEK, INC.
TABLE 224 DISTEK, INC.: BUSINESS OVERVIEW
11.14 ABEC, INC.
TABLE 225 ABEC INC.: BUSINESS OVERVIEW
11.15 ABLE CORPORATION & BIOTT CORPORATION
TABLE 226 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW
11.16 G&G TECHNOLOGIES, INC.
TABLE 227 G&G TECHNOLOGIES INC.: BUSINESS OVERVIEW
11.17 SOLIDA BIOTECH GMBH
TABLE 228 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
11.18 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
TABLE 229 SATAKE CHEMICAL EQUIPMENT MFG. LTD: BUSINESS OVERVIEW
11.19 STOBBE PHARMA GMBH
TABLE 230 STOBBE PHARMA GMBH: BUSINESS OVERVIEW
11.20 CELLTAINER BIOTECH BV
TABLE 231 CELLTAINER BIOTECH BV: BUSINESS OVERVIEW
11.21 MEISSNER FILTRATION PRODUCTS, INC.
TABLE 232 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW
11.22 BBI-BIOTECH
TABLE 233 BBI BIOTECH: BUSINESS OVERVIEW
11.23 PIERRE GU?RIN
TABLE 234 PIERRE GUERIN: BUSINESS OVERVIEW
11.24 KUHNER AG
TABLE 235 KUHNER AG: BUSINESS OVERVIEW
11.25 OMNIBRX BIOTECHNOLOGIES
*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY SOURCES: SINGLE-USE BIOPROCESSING MARKET
2.2 MARKET SIZE ESTIMATION
FIGURE 2 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
FIGURE 3 SINGLE-USE BIOPROCESSING MARKET: FINAL MARKET (USD BILLION)
FIGURE 4 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOPROCESSING MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
2.3.1 KEY INDUSTRY INSIGHTS
2.3.2 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 6 MEDIA BAGS AND CONTAINERS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
FIGURE 7 FILTRATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET DURING THE FORECAST PERIOD
FIGURE 8 CROS AND CMOS TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET DURING THE FORECAST PERIOD
FIGURE 9 GEOGRAPHICAL SNAPSHOT: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET IN 2020
4 PREMIUM INSIGHTS
4.1 SINGLE-USE BIOPROCESSING MARKET OVERVIEW, 2021 VS. 2026
FIGURE 10 RISING DEMAND FOR BIOPHARMACEUTICALS IS A KEY DRIVER FOR
MARKET GROWTH
4.2 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT &
COUNTRY (2021)
FIGURE 11 MEDIA BAGS AND CONTAINERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
4.3 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
FIGURE 12 THE FILTRATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET IN 2020
4.4 SINGLE-USE BIOPROCESSING MARKET, BY END USER
FIGURE 13 BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE END USERS SEGMENT IN 2020
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 14 SINGLE-USE BIOPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 The growing demand for biopharmaceuticals
5.1.1.2 Reduced investments for single-use bioprocessing technologies
FIGURE 15 IMPACT ON VARIOUS PARAMETERS: SINGLE-USE SYSTEMS VS. STAINLESS STEEL SYSTEMS
5.1.1.3 Faster implementation and lower risk of product cross-contamination
5.1.2 RESTRAINTS
5.1.2.1 Issues related to leachables and extractables
TABLE 1 KEY EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging markets
5.1.3.2 Patent Expiry
FIGURE 16 US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
5.1.4 CHALLENGES
5.1.4.1 Waste disposal
TABLE 2 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
5.1.4.2 Issues associated with scalability
5.2 PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS (2020)
5.2.1 THREAT FROM NEW ENTRANTS
5.2.2 THREAT FROM SUBSTITUTES
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF COMPETITIVE RIVALRY
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF THE ECOSYSTEM OF SINGLE-USE BIOPROCESSING: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.4 PRICING ANALYSIS
TABLE 3 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS BY REGION (2019)
5.5 TECHNOLOGICAL ANALYSIS
5.6 IMPACT OF COVID-19 OUTBREAK ON THE SINGLE-USE BIOPROCESSING MARKET
6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 5 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
6.2 SINGLE-USE MEDIA BAGS AND CONTAINERS
6.2.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESSING OPERATIONS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
TABLE 6 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2017–2020 (USD MILLION)
TABLE 7 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2021–2026 (USD MILLION)
TABLE 8 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 9 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 10 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 11 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 12 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 13 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
6.3 SINGLE-USE ASSEMBLIES
6.3.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE ASSEMBLIES
TABLE 14 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 17 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 18 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 19 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 20 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 21 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.4 SINGLE-USE BIOREACTORS
6.4.1 SINGLE-USE BIOREACTOR SYSTEMS OFFER GREAT FLEXIBILITY OF OPERATIONS
TABLE 22 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 25 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 26 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 27 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 29 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.5 DISPOSABLE MIXERS
6.5.1 DISPOSABLE MIXERS OFFER REDUCED RISK OF CROSS CONTAMINATION WHICH DRIVES THE GROWTH OF THIS SEGMENT
TABLE 30 DISPOSABLE MIXERS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 31 DISPOSABLE MIXERS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 32 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 33 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 34 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 35 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 36 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 37 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.6 OTHER PRODUCTS
TABLE 38 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 41 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 42 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 43 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 45 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 46 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 47 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
7.2 FILTRATION
TABLE 48 FILTRATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 49 FILTRATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 51 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 52 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 53 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 54 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 55 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.3 STORAGE
7.3.1 SINGLE-USE STORAGE SYSTEMS OFFER COST SAVINGS ON STERILIZATION PROCESS
TABLE 56 STORAGE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 57 STORAGE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 59 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 60 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 61 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 62 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 63 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.4 CELL CULTURE
7.4.1 SINGLE-USE CELL CULTURE PRODUCTS OFFER REDUCED RISK OF CONTAMINATION
TABLE 64 CELL CULTURE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 65 CELL CULTURE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 67 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 68 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 69 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 70 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 71 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.5 MIXING
7.5.1 DISPOSABLE MIXING SYSTEMS ARE COST-EFFICIENT, PREVENTING CLEANING AND STERILIZATION CHARGES
TABLE 72 MIXING APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 73 MIXING APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 75 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 76 EUROPE: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 77 EUROPE: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 79 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
7.6 PURIFICATION
7.6.1 SINGLE-USE PURIFICATION PRODUCTS ARE INCREASINGLY IN DEMAND OWING TO FLEXIBILITY OF USE
TABLE 80 PURIFICATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 81 PURIFICATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
TABLE 82 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 83 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 84 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 85 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 87 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
8 SINGLE-USE BIOPROCESSING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 88 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 89 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
8.2 BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES
8.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOPROCESSING EQUIPMENT IN THIS END-USER SEGMENT
TABLE 90 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION)
TABLE 91 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 93 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 94 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 95 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 96 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 97 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF CROS AND CMOS
TABLE 98 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2017–2020 (USD MILLION)
TABLE 99 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2021–2026 (USD MILLION)
TABLE 100 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 101 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 102 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 103 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 104 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 105 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS &
CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES
TO DRIVE THE MARKET GROWTH
TABLE 106 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)
TABLE 107 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)
TABLE 108 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 109 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 110 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 111 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 113 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
9 SINGLE-USE BIOPROCESSING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 114 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 115 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
TABLE 116 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 117 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 118 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 119 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 120 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
9.2.1 US
9.2.1.1 The growing focus on biopharmaceutical production in the US drives the market growth
TABLE 124 US: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.2.2 CANADA
9.2.2.1 The increasing incidences of lifestyle diseases such as cancer drive the market growth for biologics in Canada
TABLE 130 CANADA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.3 EUROPE
TABLE 136 EUROPE: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing adoption of single-use bioprocessing equipment by biopharma and CDMO companies to drive the market growth
TABLE 144 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 145 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 146 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 147 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 148 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 149 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies in the UK
TABLE 150 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 151 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 152 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 153 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 154 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 155 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing investments in life sciences R&D infrastructure development to drive the market growth in France
TABLE 156 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 157 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 158 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 159 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 160 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 161 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.4 REST OF EUROPE (ROE)
TABLE 162 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 163 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 164 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 165 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 166 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 167 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
TABLE 168 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
FIGURE 21 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
9.4.1 CHINA
9.4.1.1 Government support and significant private investments to drive the market growth in China
TABLE 176 CHINA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing biomanufacturing investments to favor the market growth
TABLE 182 JAPAN: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Low manufacturing and labor costs make India a lucrative country for single-use bioprocessing equipment manufacturers
TABLE 188 INDIA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 194 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 195 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 196 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 197 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 198 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 199 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.5 LATIN AMERICA (LATAM)
9.5.1 BRAZIL ACCOUNTS FOR THE LARGEST SHARE OF THE LATAM REGION FOR SINGLE-USE BIOPROCESSING IN 2020
TABLE 200 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 201 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 202 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 203 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 204 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 205 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA (MEA)
9.6.1 THE GROWTH OF THE BIOTECHNOLOGY INDUSTRY IN THIS REGION DRIVES THE WIDE ADOPTION OF SINGLE-USE BIOPROCESSING PRODUCTS
TABLE 206 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
TABLE 207 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 208 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 209 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 210 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 211 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 MARKET EVALUATION FRAMEWORK
10.2 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION QUADRANT
10.2.1 STARS
10.2.2 EMERGING LEADERS
10.2.3 PERVASIVE
10.2.4 PARTICIPANTS
FIGURE 22 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION MATRIX, 2020
10.3 MARKET RANK ANALYSIS
FIGURE 23 SINGLE-USE BIOPROCESSING MARKET: MARKET RANKING OF KEY PLAYERS (2020)
10.4 COMPETITIVE SCENARIO
10.4.1 KEY PRODUCT LAUNCHES
10.4.2 KEY ACQUISITIONS
10.4.3 KEY PARTNERSHIPS AND AGREEMENTS
10.4.4 KEY EXPANSIONS
11 COMPANY PROFILES
(Business overview, Products offered, Recent Developments,SWOT Analysis, MNM view)*
11.1 SARTORIUS STEDIM BIOTECH
TABLE 212 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
FIGURE 24 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
11.2 DANAHER CORPORATION
TABLE 213 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.3 THERMO FISHER SCIENTIFIC
TABLE 214 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.4 MERCK KGAA
TABLE 215 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.5 GETINGE AB
TABLE 216 GETINGE AB: BUSINESS OVERVIEW
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2020)
11.6 EPPENDORF AG
TABLE 217 EPPENDORF AG: BUSINESS OVERVIEW
FIGURE 29 EPPENDORF: COMPANY SNAPSHOT (2020)
11.7 CORNING
TABLE 218 CORNING: BUSINESS OVERVIEW
FIGURE 30 CORNING COMPANY SNAPSHOT (2020)
11.8 ENTEGRIS
TABLE 219 ENTEGRIS: BUSINESS OVERVIEW
FIGURE 31 ENTEGRIS COMPANY SNAPSHOT (2020)
11.9 AVANTOR
TABLE 220 AVANTOR: BUSINESS OVERVIEW
FIGURE 32 AVANTOR: COMPANY SNAPSHOT (2020)
11.10 CESCO BIOENGINEERING CO., LTD.
TABLE 221 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
11.11 CELLEXUS
TABLE 222 CELLEXUS: BUSINESS OVERVIEW
11.12 PBS BIOTECH, INC.
TABLE 223 PBS BIOTECH, INC.: BUSINESS OVERVIEW
11.13 DISTEK, INC.
TABLE 224 DISTEK, INC.: BUSINESS OVERVIEW
11.14 ABEC, INC.
TABLE 225 ABEC INC.: BUSINESS OVERVIEW
11.15 ABLE CORPORATION & BIOTT CORPORATION
TABLE 226 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW
11.16 G&G TECHNOLOGIES, INC.
TABLE 227 G&G TECHNOLOGIES INC.: BUSINESS OVERVIEW
11.17 SOLIDA BIOTECH GMBH
TABLE 228 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
11.18 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
TABLE 229 SATAKE CHEMICAL EQUIPMENT MFG. LTD: BUSINESS OVERVIEW
11.19 STOBBE PHARMA GMBH
TABLE 230 STOBBE PHARMA GMBH: BUSINESS OVERVIEW
11.20 CELLTAINER BIOTECH BV
TABLE 231 CELLTAINER BIOTECH BV: BUSINESS OVERVIEW
11.21 MEISSNER FILTRATION PRODUCTS, INC.
TABLE 232 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW
11.22 BBI-BIOTECH
TABLE 233 BBI BIOTECH: BUSINESS OVERVIEW
11.23 PIERRE GU?RIN
TABLE 234 PIERRE GUERIN: BUSINESS OVERVIEW
11.24 KUHNER AG
TABLE 235 KUHNER AG: BUSINESS OVERVIEW
11.25 OMNIBRX BIOTECHNOLOGIES
*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
Single-use bioprocessing technology is a rapidly evolving technology that is used in the development of disposable bio-processing equipment and accessories to manufacture biopharmaceutical products. The global single-use bioreactors market is expected to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
Some of the major factors driving the growth of the single-use bioreactors market (SUBs) are improved returns on investment for small companies and startups and reduced complexity of automation. However, limitations related to scaling, issues regarding leachables and extractables, and difficulties in meeting the good manufacturing practice (GMP) standards are some of the factors restraining the growth of this market.
In this report, the SUBs market is broadly segmented into technology, type of cells, molecule type, end user, and geography.
The single-use bioprocessing technology, which emerged in the 1970s with the use of vials and pipettes, has transformed significantly over the last decade. The single-use bioprocessing technology is a rapidly evolving technology that is used in the development of disposable bio-processing equipment and accessories to manufacture biopharmaceutical products. This disposable equipment mainly helps to reduce the costs associated with the usage of complex steps such as sterilization, cleaning, and maintenance of steel-based bioreactor systems and accessories. The first single-use bioreactors—Wave rocker platforms (now from GE Healthcare)—entered the market about 10 years ago. Currently, for bioreactors, the single-use technology is mainly used for a wide range of processes, from upscale bioprocessing to final formulation and filling.
Factors such as improved returns on investment for small companies and startups, reduced complexity in automation, and ease in cultivation of marine organisms like algae are the key drivers for the growth of the global SUBs market. On the other hand, extractability and leachability issues regarding disposable components like plastic bags (used in bioreactors), breakage of bags, and environmental and economic concerns are the major factors that are restraining the growth of the SUBs market.
Wave-induced motion SUBs were launched in early 2000s. With successful application over the years, they are one of the widely used SUBs. These SUBs are based on the rocking motion that is used for mixing the contents of the bioreactor. This is one of the oldest agitation technologies used in SUBs. This technology has witnessed highest adoption as it requires lower investment costs and simpler and cheaper validation as compared to stirred tank bioreactors. Moreover, wave-induced motion SUBs conduct bubble-free surface aeration that result in reduced foaming and flotation compared to stirred tank bioreactors. Foaming and flotation are problems normally encountered while culturing cells, especially plant cells such as algae, which causes reduction in the working volume of bioreactors.
In wave-induced technology, both mass and energy transfer takes place; this contributes to final product and process efficiency. However, the difficulty in cultivation of aerobic microbes that require high oxygen transfer rate is the major disadvantage of wave-induced motion SUBs.
The wave-induced motion SUBs market is expected to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
